TJ191

Based on 2 reference(s) in Google Scholar 8 10 2

Axon 3076

CAS [1522415-97-9]

MF C13H21NO2S
MW 255.38

  • Purity: 100%
  • Soluble in DMSO

TJ191

Description

TJ191 is a potent and selective anti-cancer molecule with pronounced activity against human malignant T-cells expressing low levels of TβRIII. TJ191 selectively inhibits the proliferation of, and induces apoptosis in, various T-cell-derived hematological malignant cell lines. TJ191 selectively targets certain cancer cells without affecting the proliferation of other cancer cells or normal fibroblasts or immune cells (over 600-fold selectivity).

KEYWORDS: TJ191 | supplier | Anticancer agent | TJ191 | TJ191 | CAS [1522415-97-9] | TGF-β | TGF-βR | Inhibitor | Receptors | Betaglycan

Order
Size Unit Price Stock
10 mg €120.00 In Stock
50 mg €360.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...